levetiracetam

Generic: levetiracetam

Labeler: bluepoint laboratories
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name levetiracetam
Generic Name levetiracetam
Labeler bluepoint laboratories
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

levetiracetam 750 mg/1

Manufacturer
BluePoint Laboratories

Identifiers & Regulatory

Product NDC 68001-114
Product ID 68001-114_3244b556-1f56-2c07-e063-6394a90a4f52
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA091399
Listing Expiration 2026-12-31
Marketing Start 2014-02-13

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68001114
Hyphenated Format 68001-114

Supplemental Identifiers

RxCUI
807832 846378
UPC
0368001114066 0368001113069
UNII
44YRR34555
NUI
N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name levetiracetam (source: ndc)
Generic Name levetiracetam (source: ndc)
Application Number ANDA091399 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 750 mg/1
source: ndc
Packaging
  • 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-114-06)
source: ndc

Packages (1)

68001-114-06 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-114-06)

Ingredients (1)

levetiracetam (750 mg/1)

Linked Drug Pages (1)

Levetiracetam ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3244b556-1f56-2c07-e063-6394a90a4f52", "openfda": {"nui": ["N0000008486"], "upc": ["0368001114066", "0368001113069"], "unii": ["44YRR34555"], "rxcui": ["807832", "846378"], "spl_set_id": ["402b488c-1733-4bf7-a7a8-b60805b022c9"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-114-06)", "package_ndc": "68001-114-06", "marketing_start_date": "20140213"}], "brand_name": "Levetiracetam", "product_id": "68001-114_3244b556-1f56-2c07-e063-6394a90a4f52", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "68001-114", "generic_name": "Levetiracetam", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Levetiracetam", "active_ingredients": [{"name": "LEVETIRACETAM", "strength": "750 mg/1"}], "application_number": "ANDA091399", "marketing_category": "ANDA", "marketing_start_date": "20140213", "listing_expiration_date": "20261231"}